CN Patent

CN103281902A — 右美托咪定预混合制剂

Assigned to Hospira Inc · Expires 2013-09-04 · 13y expired

What this patent protects

本发明公开的主题涉及包含右美托咪定或其药学上可接受的盐的药物组合物，其中所述组合物配制为用于肠胃外施用给受试者的液体，且其中所述组合物作为预混合物配置在密封容器内。所述药物组合物可以用于例如患者的围手术期医护或用于镇静。

USPTO Abstract

本发明公开的主题涉及包含右美托咪定或其药学上可接受的盐的药物组合物，其中所述组合物配制为用于肠胃外施用给受试者的液体，且其中所述组合物作为预混合物配置在密封容器内。所述药物组合物可以用于例如患者的围手术期医护或用于镇静。

Drugs covered by this patent

Patent Metadata

Patent number
CN103281902A
Jurisdiction
CN
Classification
—
Expires
2013-09-04
Drug substance claim
No
Drug product claim
No
Assignee
Hospira Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.